Top Selling Biologics Market, 2021-2030
Roots Analysis has announced the addition of Top
Selling Biologics Market, 2021-2030 report to its list of offerings.
As of today,
most of the top revenue generating drugs, across the globe, are biologics.
During our research, we were able to identify 67 top selling biologics (revenues equal to or above USD 500 million in 2020).
To request a
sample copy / brochure of this report, please visit this: https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-sample.html
Top selling
biologics market has so far been primarily led by industry players. Majority of
industry players have taken a step towards investing their time and resources
for the development of biologic therapies.
Genentech,
Amgen, Janssen Biotech, Sanofi and Novo Nordisk are amongst the major players
in this domain. Biogen, AstraZeneca, Merck, Bristol Myers Squibb,
GlaxoSmithKline, Alexion Pharmaceuticals, AbbVie and Novartis are other players
that have entered the Top Selling Biologics domain in the past.
It is worth
highlighting that most of the therapies are monoclonal antibodies capture the
highest share (54%) of the top
selling biologics market. This
can be attributed to the various advantages offered by them, including high
reproducibility and specificity. It is also worth mentioning that these
therapeutic modalities are being used for many cancer indications. Further,
most of the top selling biologics are currently delivered via subcutaneous
route of administration. However, most of the top selling biologics are
available in the form of vials. This can be attributed to the better sterility
assurance and reduced particle presence offered by such packaging
formats. [1]
To request a
customization to this report – https://www.rootsanalysis.com/reports/top-selling-biologics-market/request-customization.html
Key Questions
Answered
- Which biologics have achieved blockbuster status in
the last 1-2 years?
- Who are the leading players engaged in the
development of top selling biologics?
- Which key clinical conditions are presently targeted
by top selling biologics?
- What are the historical global sales of top selling
biologics?
- Which product life cycle management strategies are
most commonly adopted by players to extend the life of their top selling
products?
- What is the current annual treatment cost associated
with top selling biologics?
- Which regions have emerged as key hubs for
conducting clinical studies focused on top selling biologics?
- How has the biosimilars landscape in this market
evolved over the past few years?
- Which factors are likely to influence the evolution
of this market?
- How is the current and future market opportunity
likely to be distributed across key market segments?
For additional
details, please visit https://www.rootsanalysis.com/reports/top-selling-biologics-market.htmlOr sales@rootsanalysis.com
About Roots
Analysis
Roots Analysis
is one of the fastest growing market research companies, sharing fresh and
independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact
Details
Ben
Johnson
+1 (415) 800
3415
ben.johnson@rootsanalysis.com
Roots
Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
Comments
Post a Comment